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ABSTRACT Although much work has linked the human microbiome to specific
phenotypes and lifestyle variables, data from different projects have been challeng-
ing to integrate and the extent of microbial and molecular diversity in human stool
remains unknown. Using standardized protocols from the Earth Microbiome Project
and sample contributions from over 10,000 citizen-scientists, together with an open
research network, we compare human microbiome specimens primarily from the
United States, United Kingdom, and Australia to one another and to environmental
samples. Our results show an unexpected range of beta-diversity in human stool mi-
crobiomes compared to environmental samples; demonstrate the utility of proce-
dures for removing the effects of overgrowth during room-temperature shipping for
revealing phenotype correlations; uncover new molecules and kinds of molecular
communities in the human stool metabolome; and examine emergent associations
among the microbiome, metabolome, and the diversity of plants that are consumed
(rather than relying on reductive categorical variables such as veganism, which have
little or no explanatory power). We also demonstrate the utility of the living data re-
source and cross-cohort comparison to confirm existing associations between the
microbiome and psychiatric illness and to reveal the extent of microbiome change
within one individual during surgery, providing a paradigm for open microbiome re-
search and education.
IMPORTANCE We show that a citizen science, self-selected cohort shipping samples
through the mail at room temperature recaptures many known microbiome results
from clinically collected cohorts and reveals new ones. Of particular interest is inte-
grating n  1 study data with the population data, showing that the extent of mi-
crobiome change after events such as surgery can exceed differences between dis-
tinct environmental biomes, and the effect of diverse plants in the diet, which we
confirm with untargeted metabolomics on hundreds of samples.
KEYWORDS citizen science, microbiome
The human microbiome plays a fundamental role in human health and disease.While many studies link microbiome composition to phenotypes, we lack under-
standing of the boundaries of bacterial diversity within the human population and
the relative importance of lifestyle, health conditions, and diet to underpin preci-
sion medicine or to educate the broader community about this key aspect of human
health.
We launched the American Gut Project (AGP; http://americangut.org) in November
2012 as a collaboration between the Earth Microbiome Project (EMP) (1) and the
Human Food Project (HFP; http://humanfoodproject.com/) to discover the kinds of
microbes and microbiomes “in the wild” via a self-selected citizen-scientist cohort. The
EMP characterizes global microbial taxonomic and functional diversity, and the HFP
focuses on understanding microbial diversity across human populations. As of May
2017, the AGP included microbial sequence data from 15,096 samples from 11,336
human participants, totaling over 467 million (48,599 unique) 16S rRNA V4 gene
fragments (abbreviated 16S). Our project informs citizen-scientist participants about
their own microbiomes by providing a standard report (Fig. 1A) and deposits all
deidentified data into the public domain on an ongoing basis without access restric-
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tions (see Table S1 in the supplemental material). This reference database characterizes
the diversity of the industrialized human gut microbiome on an unprecedented scale;
reveals novel relationships with health, lifestyle, and dietary factors; and establishes the
AGP resource and infrastructure as a living platform for discovery.
RESULTS
Cohort characteristics. AGP participants primarily reside in the United States (n 
7,860). However, interest in the AGP rapidly expanded beyond the United States to the
United Kingdom (n  2,518) and Australia (n  321), with 42 other countries or territories
also represented (Fig. 1A; see also Table S1 in the supplemental material). Participants in the
United States inhabit urban (n  7,317), rural (n  29), and mixed (n  98) communities
(2010 U.S. Census data based on participant ZIP codes) and span greater ranges of age,
race, and ethnicity than other large-scale microbiome projects (2–6).
Using a survey modified from references 7 and 8, participants reported general
health status, disease history, and lifestyle data (Table S2 and Text S1). In accordance
with our institutional review board (IRB), all survey questions were optional (median
per-question response, 70.9% [Table S2]). Additionally, 14.8% of participants completed
FIG 1 Population characteristics. (A) Participants across the world have sent in samples to American Gut, although the primary geographic regions of
participation are in North America and the United Kingdom; the report that a participant receives is depicted. (B) The primary sample breakdown for subsequent
analyses. Red denotes the reasons that samples were removed. (C) Between the two largest populations, the United States (n  6,634) and the United Kingdom
(n  2,071), we observe a significant difference in alpha-diversity. (D) In a meta-analysis, the largely industrialized population that makes up American Gut
exhibits significant differential abundances compared to nonindustrialized populations.
American Gut: an Open Platform for Microbiome Research
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a validated picture-based food frequency questionnaire (FFQ) (VioScreen; http://www
.viocare.com/vioscreen.html), and responses correlated well with primary survey diet
responses (Table S2).
We focused our primary investigative efforts on a “healthy adult” subset (n  3,942)
of individuals aged 20 to 69 years with body mass indexes (BMIs) ranging between 18.5
and 30 kg/m2; no self-reported history of inflammatory bowel disease (IBD), diabetes,
or antibiotic use in the past year; and at least 1,250 16S sequences/sample (Fig. 1B
and S1B).
The two largest populations in the data set (United States and United Kingdom)
differed significantly in alpha-diversity, with Faith’s phylogenetic diversity (PD) higher in
U.K. samples (9) (Mann-Whitney test P  1  1015) (Fig. 1C). One balance (10) (a
log-ratio compositional transform) explained most of the taxonomic separation be-
tween U.S. and U.K. samples (area under the curve [AUC]  77.7%; analysis of variance
[ANOVA] P  1.01  1078, F  386.85) (Fig. S1C and Table S3). To understand how
these two populations differed from others, we compared adult AGP samples (pre-
dominantly from industrialized regions) to samples from adults living traditional life-
styles (6, 11, 12) (e.g., hunter-gatherer and remote agrarian populations). As previously
observed (6), samples from industrial and traditional populations separated in principal-
coordinate analysis (PCoA) space of unweighted UniFrac distances (13) (Fig. S1D).
UniFrac is a formal distance metric (14) which computes a dissimilarity based on the
amount of unique phylogenetic branch length between two samples. These distances
show a greater variation within industrial populations than within traditional popula-
tions (2) and facile separation based on microbial taxonomy (industrial versus nonin-
dustrial agrarian, AUC  98.9%; ANOVA P  1.52  10260, F  1,265.8; industrial
versus hunter-gatherer, AUC  99.5%; ANOVA P  4.48  10227, F  1,092.35) (Fig. 1D
and Table S3).
Removal of bacterial blooms. An important practical question is whether self-
collected microbiome samples can match those from better-controlled studies. Most
AGP samples are stools collected on dry swabs and shipped without preservative
to minimize costs and avoid exposure to toxic preservatives. Escherichia coli and a
few other taxa grow in transit, so based on data from controlled-storage studies as
previously described (15), we removed sub-operational taxonomic units (sOTUs) (16)
(median of 7.9% of sequences removed per sample) shown to bloom.
We further characterized the impact of these organisms through culturing, high-
performance liquid chromatography mass spectrometry (HPLC-MS) analysis of cultured
isolates, and shotgun metagenomics of the primary samples and storage controls (15,
17). Culturing primary specimens stored at 80°C (United States, n  116; United
Kingdom, n  73; other, n  25) showed a strong correlation between the fraction of
sequences reported as blooms in 16S sequencing and positive microbial growth
following overnight incubation under aerobic conditions (Fig. 2A). Culture supernatants
were characterized using HPLC-MS; most metabolites in these supernatants were
absent from the primary specimens (Fig. 2B; see method details in Text S1). We
sequenced draft genomes of 169 isolates; of these, 65 contained the exact E. coli 16S
sequence in the published bloom filter (15). To characterize the impact of the 16S filter
for blooms used exactly as described in reference 15, we computed effect sizes over the
participant covariates and technical parameters for 9,511 individual participant sam-
ples, including and excluding blooms (complete list in Table S2), and observed tight
correlations for both unweighted (Fig. 2C) (Pearson r  0.91, P  3.76  1057;
Spearman r  0.90, P  9.45  1055) and weighted (Fig. 2D) (Pearson r  0.42, P 
1.71  106; Spearman r  0.58, P  1.03  109) UniFrac values, suggesting that the
presence of the blooms does not substantially alter effect sizes of the study variables.
An outlier on the quantitative metric (weighted UniFrac) is present and corresponds to
a variable representing the fraction of bloom reads in a sample. In Text S1, we further
compare the ranking of these effect sizes to reference 17. The filter for 16S blooms acts
by removing exact sOTUs from the data set prior to rarefaction. This filter is applied to
McDonald et al.
May/June 2018 Volume 3 Issue 3 e00031-18 msystems.asm.org 4
 on O
ctober 29, 2020 at U
niversitatsbibliothek
http://m
system
s.asm
.org/
D
ow
nloaded from
 
all samples in the data set, including samples from other studies when performing
meta-analyses.
Novel taxa and microbiome configurations. To better understand human micro-
biome diversity, we placed AGP samples in the context of the EMP (1). Building on
FIG 2 Blooms and effect sizes. (A) The fraction of 16S reads that recruit to bloom reads defined by Amir et al. (15) is strongly associated with the likelihood for
microbial growth under aerobic culture conditions on rich medium. (B) Overlap of mass spectral features (consensus MS/MS cluster nodes; see Materials and
Methods, “Molecular networking”) between AGP samples and blooms. (C) Unweighted UniFrac effect sizes. The inset shows the correlation of effect sizes when
including or excluding the bloom 16S reads (Pearson r  0.91, P  3.76  1057). (D) Weighted UniFrac effect sizes. The inset shows the correlation of the effect
sizes when including or excluding bloom 16S reads (Pearson r  0.42, P  1.71  106); the outlier is the 16S bloom fraction of the sample.
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earlier work that revealed a striking difference between host-associated and environ-
mental microbiomes (18), we found that the distances between pairs of human gut
microbiomes (just one body site in one vertebrate) are often comparable to the
distances between completely different types of environments and that even the first
two dimensions of a PCoA plot capture this intuition visually (Fig. 3A). This intuition is
confirmed by PERMDISP (homogeneity of dispersion) analysis: on average, a randomly
chosen AGP fecal sample was more likely to be close to the centroid of the AGP fecal
distribution (distances in the range of 0.1 to 0.2) than a randomly chosen EMP sample
and was less distant on average from the centroid overall (P  0.001, PERMDISP).
However, the maximum distance from the centroid was greater for AGP than EMP (0.65
versus 0.58; no statistical analysis possible because this is a single value), matching the
intuition from the PCoA plot that the dispersion of the AGP samples is large compared
to individual environments and that the extremes of the spread are comparable to that
of the EMP. Because the maximum distance from the centroid increases with the
number of samples, this distance would have been expected to be greater for the EMP,
which is a larger data set.
Inserting the sOTU fragments of AGP and EMP samples into a Greengenes (19)
reference phylogenetic tree using SATé-enabled Phylogenetic Placement (SEPP) (20)
(Fig. 3B) showed that the AGP population harbored much broader microbial diversity,
as measured by phylogenetic diversity, than the Human Microbiome Project (HMP) (5).
FIG 3 OTU and beta-diversity novelty. (A) The AGP data placed into the context of extant microbial diversity at a global scale. (B) A phylogenetic tree showing
the diversity spanned by the AGP and the HMP in the context of Greengenes and the EMP. (C and D) sOTU novelty over increasing numbers of samples in the
AGP (C); the AGP appears to have begun to reach saturation and is contrasted with the data from the work of Yatsunenko et al. (6) (D), which, unlike the AGP,
had extremely deep sequencing per sample. (E) The minimum observed UniFrac distance between samples over increasing numbers of samples for the AGP
and the HMP; the inset is from 0 to 500 samples. (F) An AGP “trading card” of an sOTU of interest (shown in full in Fig. S2).
McDonald et al.
May/June 2018 Volume 3 Issue 3 e00031-18 msystems.asm.org 6
 on O
ctober 29, 2020 at U
niversitatsbibliothek
http://m
system
s.asm
.org/
D
ow
nloaded from
 
While the AGP vastly exceeds the phylogenetic diversity observed in the HMP (Faith’s
PD, 1,579.6 versus 338.2), both data sets are dwarfed by the breadth of bacterial and
archaeal phylogenetic diversity in environmental samples (Faith’s PD, 17,740.6). This
result is expected based on the relative size of the data sets (HMP  AGP  EMP), as
Faith’s PD increases with sampling effort until the diversity of a habitat is saturated,
which has not yet been achieved for any of these types of samples. We confirmed that
these differences were statistically significant (P  0.001) by bootstrap resampling
samples from each study, measuring the distances again, and examining the fraction of
the time that the rank order of the PD of the studies differed from that reported (0 of
1,000 replicates). Examining sOTUs over increasing numbers of samples, we observed
a reduction in the discovery rate of novel sOTUs starting around 3,000 samples,
emphasizing the need for focused sampling efforts outside the present AGP population
(Fig. 3C). The importance of sample size for detecting novel microbes and microbiomes
is apparent when contrasted with the work of Yatsunenko et al. (6), which contained
hundreds of samples from three distinct human populations at ~1 million sequences/
sample (Fig. 3D). This effect is magnified in beta-diversity analysis, where the AGP has
saturated the configuration space, and new samples are not “distant” from existing
samples (Fig. 3E). To encourage broad scientific engagement with sOTUs found in the
AGP, we adapted the EMP “trading cards” for sOTUs (Fig. 3F and S2).
Temporal and spatial analyses. Longitudinal samples are required for understand-
ing human microbiome dynamics (21). We examined 565 individuals who contributed
multiple samples and observed an increasing trend of intrapersonal divergence with
time. Still, over time individuals resemble themselves more than others, even after
1 year (Fig. 4A).
Recent reports suggest that the microbes of human bodies (8), like those of homes
(22), are influenced mostly by local phenomena rather than regional biogeography (23),
and accordingly, we observed only weak geographic associations with sOTUs (Fig. 4B),
no significant distance-decay relationships (Fig. 4C), and, with Bray-Curtis distance, only
a weak effect at neighborhood sizes of ca. 100 km (Mantel r  0.036, Benjamini-
Hochberg adjusted P  0.03) to 1,000 km (Mantel r  0.016, Benjamini-Hochberg
adjusted P  0.03) (Fig. 4D).
We tested whether patterns in individual longitudinal sample sets could be better
explained when placed in the context of the AGP by integrating samples collected from
(i) a time series of 58 time points from one subject (designated LS), prior to and
following a large bowel resection; (ii) two time points from 121 patients in an intensive
care unit (ICU) (24); (iii) samples from the “extreme” diet study from the work of David
et al. (25); and (iv) samples from the Hadza hunter-gatherers for additional context (22).
Through the longitudinal sampling of LS, dramatic pre- and postmicrobial configuration
changes that exceeded the span of microbial diversity associated with the AGP pop-
ulation were observed (Fig. 4E; animated in reference 26). Immediately after surgery,
the subject’s samples more closely resembled those of ICU patients (Kruskal-Wallis H 
79.774, P  4.197  1019) (Fig. S2A to C) and showed a persistent state change upon
return to the AGP fecal space. Remarkably, the UniFrac distance between the samples
immediately prior to and following the surgery was almost identical to the distance
between a marine sediment sample and a plant rhizosphere sample (unweighted
UniFrac distance of 0.78). Furthermore, the observed state change in LS is not system-
atically observed in the extreme diet study (Fig. S2D) (PERMANOVA [permutational
multivariate analysis of variance] not significant [NS] when controlling for individual).
Despite extensive dietary shifts, these subjects do not deviate from the background
AGP context.
Dietary plant diversity. The self-reported dietary data suggested, unexpectedly,
that the number of unique plant species that a subject consumes is associated with
microbial diversity, rather than self-reported categories such as “vegan” or “omnivore”
(Fig. 2C and D). Principal-component analysis (PCA) of FFQ responses (Fig. 5A) revealed
clusters associated with diet types such as “vegan.” However, these dietary clusters did
American Gut: an Open Platform for Microbiome Research
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FIG 4 Temporal and spatial patterns. (A) Five hundred sixty-five individuals had multiple samples. Distances between
samples within an individual shown at 1 month, 2 months, etc., out to over 1 year; between-subject distances are
(Continued on next page)
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not significantly relate to microbiome configurations (Fig. 5B) (Procrustes [Fig. 5A] M2 
0.988). We therefore characterized the impact of dietary plant diversity, as measured
using food frequency questionnaires and mass spectrometry (Fig. 5C and D), on the
microbial community.
Using a partial least-squares (PLS) approach (10), we identified several putative
short-chain fatty acid (SCFA) fermenters associated with eating more than 30 types of
plants, including sOTUs putatively of the species Faecalibacterium prausnitzii and of the
genus Oscillospira (27) (AUC  68.5%; ANOVA P  8.9  1039, F  177.2) (Fig. 5E and
Table S3). These data suggest community-level changes associated with microbial
fermentation of undigested plant components. Because bacteria differ in their carbo-
hydrate binding modules and enzymes that hydrolyze diverse substrates in the gut (28),
a diet containing various types of dietary fibers and resistant starches likely supports a
more diverse microbial community (29, 30). Studies suggest that these types of
responses in the gut microbiome to a high-plant diet may be common across verte-
brates. For example, core fecal taxa of herbivorous mammals (both hindgut fermenters
and ruminants) have been identified to include both Prevotella and Ruminococcaceae
(31, 32). Oscillospira in particular has been found to increase in omnivorous lizards fed
a plant-rich diet (33).
Plant consumption was also associated with a reduction in certain antibiotic resis-
tance genes. Individuals who consume more than 30 types of plants per week com-
pared to those who consume 10 or fewer plants per week had significantly reduced
abundance of antibiotic resistance genes for aminoglycosides, chloramphenicol, and
major facilitator superfamily (MFS) transporters (antibiotic efflux pumps).
To test these effects in the stool metabolome, we performed HPLC-MS annotation
and molecular networking (34, 35) on a subset of fecal samples (n  219), preferentially
selecting individuals at the extremes of plant type consumption, i.e., eating 10 or 30
different types of plants per week. Several fecal metabolites differed between the two
groups, with one key discriminating feature annotated as octadecadienoic acid (anno-
tation level 2 according to the 2007 metabolomics initiative [36]). Further investigation
using authentic standards revealed that the detected feature was comprised of multiple
isomers, including linoleic acid (LA) and conjugated linoleic acid (CLA). CLA abundance
did not correlate with dietary CLA consumption as determined by the FFQ (dietary
[Fig. 5C]; Spearman r  0.16; P  0.15) but was significantly higher in individuals
consuming 30 types of plants and those consuming more fruits and vegetables
generally (Fig. 5D) (one-sided t test; P  105). CLA is a known end product of LA
conversion by lactic acid bacteria in the gut, such as Lactobacillus plantarum (37) and
Bifidobacterium spp. (38). FFQ-based dietary levels of LA and MS-detected LA did not
differ significantly between groups (Fig. S3), suggesting that their different micro-
biomes may differentially convert LA to CLA. Several other putative octadecadienoic
acid isomers were also detected (Fig. 5F), some strongly correlated with plant con-
sumption. Determining these compounds’ identities as well as their origin and function
may uncover new links between the diet, microbiome, and health.
FIG 4 Legend (Continued)
shown as BSD. Even at 1 year, the median distance between a participant’s samples is less than the median
between-participant distance. (B) Within the United States, spatial processes of sOTUs appear driven by stochastic
processes, as few sOTUs exhibit spatial autocorrelation (Moran’s I) on the full data set or partitions (e.g., participants
older than 20 years). (C) Distance-decay relationship for Bray-Curtis dissimilarities between subject pairs that are
within a 100-km (great-circle distance) neighborhood radius of one another (Mantel test r  0.036, adjusted P  0.03).
To avoid the overplotting associated with visualization of the more than 3.4  105 pairwise comparisons, we
visualized this relationship using two-dimensional frequency bins; darker colors indicate higher-frequency bins. Solid
lines represent fits from linear models to raw data. The inset shows the largest radius (i.e., the contiguous United
States). Axes are the same as in the large panel. (D) Mantel correlogram of estimated Mantel r correlations, significance
of distance-decay relationships, and neighborhood size (x axis). Filled points represent neighborhood sizes for which
distance-decay relationships were significant (adjusted P values  0.05). (E) Characterizing a large bowel resection
using the AGP, the EMP, a hunter-gatherer population, and ICU patients in an unweighted UniFrac principal-
coordinate plot. A state change was observed in the resulting microbial community. The change in the microbial
community immediately following surgery is the same as the distance between a marine sediment sample and a plant
rhizosphere sample.
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Molecular novelty in the human gut metabolome. Our untargeted HPLC-MS
approach allowed us to search for novel molecules in the human stool metabolome,
parallel to our search for novelty in microbes and microbiome configurations described
above. Bacterial N-acyl amides were recently shown to regulate host metabolism by
interacting with G-protein-coupled receptors (GPCRs) in the murine gastrointestinal
FIG 5 Diversity of plants in a diet. (A) Procrustes analysis of fecal samples from n  1,596 individuals using principal components of the
VioScreen FFQ responses and principal coordinates of the unweighted UniFrac distances (M2  0.988) colored by diet; Procrustes tests
the fit of one ordination space to another. PCA shows grouping by diets such as vegan, suggesting that self-reported diet type is
consistent with differences in micronutrients and macronutrients as recorded by the FFQ; however, these dietary differences do not
explain relationships between the samples in 16S space. (B) The full AGP data set, including skin and oral samples, through unweighted
UniFrac and principal-coordinate analysis, highlighting a lack of apparent clustering by diet type. (C and D) Dietary conjugated linoleic
acid levels as reported by the FFQ between the extremes of plant diversity consumption (C) and the levels of CLA observed by HPLC-MS
(D). (E) Differential abundances of sOTUs (showing the most specific taxon name per sOTU) between those who eat fewer than 10 plants
per week and those who eat over 30 per week. (F) The molecules linoleic acid (LA) and conjugated linoleic acid (CLA) (only trans-,
trans-isomers are shown) were found to comprise the octadecadienoic acid found to be the key feature in this difference in number of
plants consumed.
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tract, mimicking host-derived signaling molecules (39). These agonistic molecules
regulate metabolic hormones and glucose homeostasis as efficiently as host ligands.
Manipulating microbial genes that encode enzymes that produce specific metabolites
eliciting host cellular responses could enable new drugs or treatment strategies for
many major diseases, including diabetes, obesity, and Alzheimer’s disease: roughly 34%
of all marketed drugs target GPCRs (40). We observed N-acyl amide molecules previ-
ously hypothesized but unproven to be present in the gut (39) (Fig. 6 and Fig. S4), as
well as new N-acyl amides (Fig. 6).
FIG 6 (A) Compound occurrence frequency plot. Examples of compounds originating from food (piperine, black pepper alkaloid), host (stercobilin, heme
catabolism product), and bacterial activity (lithocholic acid, microbially modified bile acid) or exogenous compounds such as antibiotics (rifaximin) or other
drugs (lisinopril, high blood pressure medication) are shown. (B to E) Alpha- and beta-diversity assessments of antibiotic (B and C) and plant (D and E) cohorts;
insets depict minimum observed beta-diversity over increasing samples.
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Levels of two N-acyl amides, annotated as commendamide (m/z 330.2635 [Fig. S4B])
and N-3-OH-palmitoyl ornithine (m/z 387.3220 [Fig. S4C]), positively correlated with a
self-reported medical diagnosis of thyroid disease (Kruskal-Wallis false discovery rate
[FDR] P  0.032, P  2.48  103, 2  11.99; N-3-OH-palmitoyl ornithine, Kruskal-
Wallis FDR P  0.048, P  5.63  103, 2  10.35). Conversely, glycodeoxycholic acid
(m/z 450.3187) was significantly higher in individuals not reporting thyroid disease
diagnosis (Kruskal-Wallis FDR P  1.28  104, P  4.41  107, 2  29.27). This cholic
acid is produced through microbial dehydroxylation, again linking gut microbiota to
endocrine function (41, 42).
Finally, we compared metabolome diversity to 16S rRNA amplicon diversity in the
samples selected for dietary plant diversity and a second set of samples selected to
explore antibiotic effects (n  256 individuals who self-reported not having taken
antibiotics in the past year [n  117] or self-reported having taken antibiotics in the
past month [n  139]; participants were matched for age, BMI, and country). By
computing a collector’s curve of observed molecular features in both cohorts (Fig. 6B
and D), we observe that, paradoxically, individuals who had taken antibiotics in the past
month (n  139) had significantly greater molecular diversity (Kruskal-Wallis H 
255.240, P  1.87  1057) than those who had not taken antibiotics in the past year
(n  117) and differed in molecular beta-diversity (Fig. 6B, inset), suggesting that
antibiotics promote unique metabolomes that result from differing chemical and
microbial environments in the gut. Notably, the diversity relationships of this set are not
reflected in 16S diversity (Fig. 6C and E), where antibiotic use shows decreased diversity
(Kruskal-Wallis H  3,983.839, P  0.0). Within the dietary plant diversity cohort, we
observed a significant increase (Kruskal-Wallis H  897.106, P  4.17  10197) in
molecular alpha-diversity associated with a high diversity of plant consumption (n 
42) compared to low plant diversity (n  43), a relationship also observed in 16S
diversity, where high dietary plant diversity increased 16S alpha-diversity (Kruskal-
Wallis H  65.817, P  4.947  1016). Recent antibiotic use (within the last 30 days)
was, counterintuitively, associated with a decrease in quinolone resistance genes (see
Materials and Methods), although not with a change in other families of antimicrobial
resistance (AMR) genes. However, these results are difficult to interpret given the wide
range of antibiotics taken by subjects, the many confounding variables, and the
self-reported nature of the data. Studies in more carefully controlled clinical environ-
ments would be needed to make more meaningful statements about the role of the
use of specific antibiotics in modifying the overall antimicrobial resistance profile of the
human gut microbiome.
Citizen science aspects of the project. The AGP engages citizen scientists both
through providing an individualized report (Fig. 1A) and through auxiliary resources to
support human microbiome research, including an online course (Gut Check: Exploring
Your Microbiome, https://www.coursera.org/learn/microbiome). Because the AGP is
crowdsourced and self-selected, and subjects generally support the cost of sample
processing, the population is unrepresentative in several important respects, including
having a lower prevalence of smoking and obesity and having higher education and
income (Fig. S1A) and underrepresentation of Hispanic and African American commu-
nities (Table S1); generalization of the results should therefore be treated with caution.
Targeted and population-based studies will be crucial for filling these cohort gaps
(Text S1). Because of the citizen science nature of the project, we sought to
minimize errors and misclassifications well known to occur in self-reported data (43).
Survey responses relied on controlled vocabularies. For analyses, we trimmed numeric
entries at extremes (e.g., weight over 200 kg or below 2.5 kg) and excluded obviously
incorrect answers (e.g., infants drinking alcohol) and samples for which necessary data
were not supplied (e.g., missing ZIP code data for spatial analyses); see the supple-
mental material for details.
To promote public data engagement, we aimed to broaden the citizen science
experience obtained by participating in AGP by “gamifying” the data and separately by
McDonald et al.
May/June 2018 Volume 3 Issue 3 e00031-18 msystems.asm.org 12
 on O
ctober 29, 2020 at U
niversitatsbibliothek
http://m
system
s.asm
.org/
D
ow
nloaded from
 
developing an online forum for microbiome data discussion and discovery. The gami-
fication introduces concepts of beta-diversity and challenges users to identify clusters
of data in principal-coordinate space (http://csb.cs.mcgill.ca/colonyb/). The forum,
called Gut Instinct (http://gutinstinct.ucsd.edu), enables participants to share lifestyle-
based insights with one another. Participants also have the option to share their AGP
sample barcodes, which will help us uncover novel contextual knowledge. Gut Instinct
now has over 1,050 participants who have collectively created over 250 questions.
Participants will soon design and run their own investigations using controlled exper-
iments to further understand their own lifestyle and the AGP data.
A living data set. The AGP is dynamic, with samples arriving from around the world
daily. This allows a living analysis, similar to continuous molecular identification and
annotation revision in the Global Natural Products Molecular Networking (GNPS)
database (34). Although the analysis presented here represents a single snapshot,
samples continued to arrive during preparation of the manuscript. For example, after
we defined the core “healthy” sample set, an exploratory analysis using matched
controls was performed by collaborators to test for correlations between mental illness
and microbiome composition (as reported in references 44 and 45). By analyzing
mental illness status (depression, schizophrenia, posttraumatic stress disorder [PTSD],
and bipolar disorder—four of the most disabling illnesses per the World Health
Organization [46]) reported by AGP participants (n  125) against matched 1:1 healthy
controls (n  125), we observed a significant partitioning using PERMANOVA in
weighted UniFrac (P  0.05, pseudo-F  2.36). These findings were reproducible within
U.S. residents (n  122, P  0.05, pseudo-F  2.58), U.K. residents (n  112, P  0.05,
pseudo-F  2.16), women (n  152, P  0.04, pseudo-F  2.35), and people 45 years
of age or younger (n  122, P  0.05, pseudo-F  2.45). We also reproduced some
previously reported differentially abundant taxa in Chinese populations using our U.K.
subset (44, 47) (Table S3). This shows that multicohort replication is possible within the
AGP (additional detail in Text S1).
DISCUSSION
The AGP provides an example of a successful crowdfunded citizen science project
that facilitates human microbiome hypothesis generation and testing on an unprece-
dented scale, provides a free data resource derived from over 10,000 human-associated
microbial samples, and both recaptures known microbiome results and yields new
ones. Ongoing living data efforts, such as the AGP, will allow researchers to document
and potentially mitigate the effects of a slow but steady global homogenization driven
by increased travel, life spans, and access to similar diets and therapies, including
antibiotics. Because the AGP is a subproject of the EMP (1), all samples were processed
using the publicly available and widely used EMP protocols to facilitate meta-analyses,
as highlighted above. Further examples of applications include assessing the stability of
AGP runs over time and comparing the AGP population to fecal samples collected from
a fecal transplant study (48) and an infant microbiome time series (49), the latter using
different DNA sequencing technology, to highlight how this context can provide
insight (50).
A unique aspect of the AGP is the open community process of assembling the
Research Network and analyzing these data, which are released immediately on data
generation. Analysis details are shared through a public forum (GitHub, https://github
.com/knightlab-analyses/american-gut-analyses). Scientific contributions to the project
were made through a geographically diverse Research Network represented here as the
American Gut Consortium, established prior to project launch and which has grown
over time. This model allows a “living analysis” approach, embracing new research-
ers and analytical tools on an ongoing basis (e.g., Qiita [http://qiita.microbio.me] and
GNPS [34]). Examples of users of the AGP as a research platform include educators at
several universities, UC San Diego Athletics, and the American Gastroenterological
Association (AGA). Details on projects using the AGP infrastructure can be found in the
supplemental material.
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The AGP therefore represents a unique citizen science data set and resource,
providing a rich characterization of microbiome and metabolome diversity at the
population level. We believe that the community process for involving participants
from sample collection through data analysis and deposition will be adopted by many
projects harnessing the power of citizen science to understand the world around and
within our own bodies.
MATERIALS AND METHODS
Participant recruitment and sample processing. Participants signed up for the project through
Indiegogo (https://www.indiegogo.com) and later FundRazr (http://fundrazr.com/). A contribution to the
project was made to help offset the cost of sample processing and sequencing (typically $99 per sample;
no requirement to contribute if another party was covering the contribution). All participants’ consent
was obtained under an approved Institutional Review Board human research subject protocol, either
from the University of Colorado Boulder (protocol no. 12-0582; December 2012 to March 2015) or from
the University of California, San Diego (protocol no. 141853; February 2015 to present). The IRB-approved
protocol specifically allows for public deposition of all data that are not personally identifying and for
return of results to participants (Fig. 1A). This research was performed in accordance with the University
of Colorado Boulder’s Institutional Review Board protocol number 12-0582 and the University of
California San Diego’s Human Research Protection Program protocol number 141853.
Self-reported metadata were collected through a web portal (http://www.microbio.me/americangut).
Samples were collected using BBL culture swabs (Becton, Dickinson and Company, Sparks, MD) and
returned by mail. Samples collected in Australia and the United Kingdom were shipped using domestic
post within each country to an aggregation site and stored at 80°C at the aggregation site until
shipment to the United States. Shipment to the United States was done on dry ice using a certified
shipping service. All samples were handled and processed in kind with other American Gut samples. For
more information, please find an extensive benchmark of shipping conditions in reference 17. All
samples were processed using the EMP protocols. Briefly, the V4 region of the 16S rRNA gene was
amplified with barcoded primers and sequenced as previously described (51). Sequencing prior to
August 2014 was done using the 515f/806r primer pair with the barcode on the reverse primer (52);
subsequent rounds were sequenced with the updated 515f/806rB primer pair with the barcode on the
forward read (52). Sequencing batches 1 to 19 and 23 to 49 were sequenced using an Illumina MiSeq;
sequencing for batches 20 and 21 was performed with an Illumina HiSeq Rapid Run, and round 22 was
sequenced with an Illumina HiSeq High-Output.
16S data processing. The 16S sequence data were processed using a sequence variant method,
Deblur v1.0.2 (16), trimming to 125 nucleotides (nt) (otherwise default parameters), to maximize the
specificity of 16S data; a trim of 125 nt was used because one sequencing round in the American Gut
used 125 cycles while the rest used 150. Following processing by Deblur, previously recognized bloom
sequences were removed (15). The Deblur sOTUs were inserted into the Greengenes 13_8 (19) 99%
reference tree using SEPP (20). SEPP uses the simultaneous alignment and tree estimation strategy
described in reference 53 to identify reasonable placements for sequence fragments within an existing
phylogeny and alignment. Taxonomy was assigned using an implementation of the RDP classifier (54) as
implemented in QIIME2 (55). Multiple rarefactions were computed, with the minimum being 1,250
sequences per sample with the analyses using the 1,250-sequence set except where noted explicitly.
Rarefaction was used to mitigate uneven sequencing depth in accordance with the benchmarking in
reference 56. Diversity calculations were computed using scikit-bio 0.5.1 with the exception of UniFrac
(13), which was computed using an unpublished algorithmic variant, Striped UniFrac (https://github
.com/biocore/unifrac), which scales to larger data sets and produces results identical to previously
published UniFrac algorithms. In brief, unweighted UniFrac computes a dissimilarity between two
samples by summing up the amount of branch length that is unique to each sample and divides this by
the sum of the branch length that is common to the two samples.
Metadata curation. To address the self-reported nature of the AGP data and the ongoing nature of
the project, basic filtering was performed on the age, height, weight, and body mass index (BMI). Height
and weight were gated to consider heights only between 48 cm and 210 cm and weight between 2.5 kg
and 200 kg. BMI calculations using values outside this range were not considered. We assumed that age
was misreported by any individual who reported a birthdate after the sample was collected. We also
assumed that age was misreported for participants who reported an age of less than 4 years but height
over 105 cm, weight over 20 kg, or any alcohol consumption. Values assumed to be incorrect were
dropped from analyses (see Fig. S1B in the supplemental material).
Sample selection. Analyses in this paper were performed on a subset of the total AGP samples. A
single fecal sample was selected for each participant with at least one fecal sample that amplified to
1,250 sequences per sample unless otherwise noted. Priority was given to samples that were associated
with VioScreen (http://www.viocare.com/vioscreen.html) metadata.
The samples used for analysis and subsets used in various analyses are described in Table S2. Briefly,
we defined the healthy subset (n  3,942) as adults aged 20 to 69 years with a BMI between 18.5 and
30 kg/m2 who reported no history of inflammatory bowel disease (IBD) or diabetes and no antibiotic use
in the last year. There were 1,762 participants who provided results for the VioScreen food frequency
questionnaire (FFQ; http://www.viocare.com/vioscreen.html). The meta-analysis with non-Western sam-
ples (n  4,643) included children over the age of 3 years and adults with a BMI of between 18.5 and
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30 kg/m2 and no reported history of inflammatory bowel disease, diabetes, or antibiotic use in the last
year.
Population-level comparisons. Population-level comparisons were calculated for all American Gut
participants living in the United States. BMI categorization was considered only for adults over the age
of 20 years, since the description of BMI in children is based on their age and sex. Education level was
considered for adults over the age of 25 years. This threshold was used to match the available data from
the U.S. Census Bureau (57). The percentage of the American Gut participants was calculated as the
fraction of individuals who reported results for that variable. U.S. population data are from the 2010
census (58); U.S. Census Bureau reports (57); Centers for Disease Control reports on obesity (59), diabetes
(60), inflammatory bowel disease (IBD) (61), and smoking (62); and a report from the Williams Institute
(63) (Table S2).
Alpha- and beta-diversity analyses within American Gut. OTU tables generated in the primary
processing step were rarefied to 1,250 sequences per sample. Shannon, observed OTU, and PD whole-
tree diversity metrics were calculated as the mean of 10 rarefactions using QIIME (9, 55). Alpha-diversity
for single metadata categories was compared with a Kruskal-Wallis test. Unweighted UniFrac distance
between samples was tested with PERMANOVA (64) and permuted t tests in QIIME.
Balances. The goal of this analysis was to design two-way classifiers to classify samples and sOTUs.
This will allow us to identify sOTUs that are strongly associated with a given environment. To do this
while accounting for issues due to compositionality, we used balances (10) constructed from partial
least-squares (65).
First, the sOTU table was centered log ratio (CLR) transformed with a pseudocount of 1. Partial
least-squares discriminant analysis (PLS-DA) was then performed on this sOTU table using a single PLS
component, using a binary categorical variable as the response and the CLR-transformed sOTU table as
the predictor. This PLS component represented an axis, which assigns scores to each OTU according to
how strongly associated it is with each class. An sOTU with a strong negative score indicates an
association for the one category, which we will designate the negative category. An sOTU with a strong
positive score indicates that sOTU is strongly associated with the other category, which we will designate
the positive category.
We assumed that PLS scores associated with each OTU were normally distributed. Specifically
scorexposi  Npos, pos2 
scorexnegi  Nneg, neg2 
scorexnulli   Nnull, null2 
where null  0, neg  0, and pos  0. To obtain estimates of these normal distributions, Gaussian
mixture models with three Gaussians were fitted from the PLS scores. Thresholds were determined from
the intersection of Gaussians. The OTUs with PLS scores less than the intersection Nnull, null
2  and N
neg, neg
2  are classified as associated with the negative category. The OTUs with PLS scores greater than
the intersection Nnull, null
2  and Npos, pos
2  are classified as associated with the positive category.
The balance was constructed as follows
b   |xpos||xneg|
|xpos|  |xneg|
loggxposgxneg
From this balance, we calculated receiver operator characteristic (ROC) curves and AUC to assess the
classification accuracy and ran ANOVA to assess the statistical significance. The dimensionality was
shrunk through some initial filtering (an sOTU must have at least 50 reads, must exist in at least 20
samples except where noted, and must have a variance over 10 to remove sOTUs that do not appear to
change), so that the number of samples is greater than the number of sOTUs to reduce the likelihood
of overfitting. This technique was used to investigate differences due to plant consumption, country of
residence, and Western versus non-Western samples and was consistently applied with the exception
that a filter of 5 samples was used for the Western–versus–non-Western analysis due to group sample
sizes.
Balances on plant consumption were constructed using partial least-squares. Only samples from
people who consumed fewer than 10 types of plants a week or more than 30 types of plants a week were
considered.
Meta-analysis of samples from the American Gut and from individuals living agrarian and
hunter-gatherer lifestyles. A meta-analysis compared fecal samples collected from healthy individuals
who were 3 years of age or older and included in the AGP data set to a previously published 16S rRNA
V4 region data set that included healthy people living an industrialized, remote agrarian, or hunter-
gatherer lifestyle (6, 11, 12). The AGP subset of healthy individuals was determined by filtering by the
metadata columns “subset_antibiotic,” “subset_ibd,” and “subset_diabetes” and, for individuals over the
age of 16 years, “subset_bmi.” All data sets were processed using the Deblur pipeline as noted above,
with the exception that all reads in the meta-analysis, including AGP data, were trimmed to 100 nt to
accommodate the read length in the work of Yatsunenko et al. (6). Bloom reads as described above were
removed from all samples. We used Striped UniFrac as noted above to estimate beta-diversity (un-
weighted UniFrac) and EMPeror software (66) version 0.9 to visualize principal coordinates. We used a
nonparametric PERMANOVA with 999 permutations to test for significant differences in fecal micro-
biomes associated with industrialized, remote agrarian, and hunter-gatherer lifestyles. All AGP samples
were considered to be from people living an industrialized lifestyle. Balances were constructed from
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partial least-squares to assess the differences between the hunter-gatherer and industrialized popula-
tions and between the remote farmers and industrialized populations.
Spatial autocorrelation. We sought to investigate distance-decay patterns—the relationship be-
tween microbial community similarity and spatial proximity—among American Gut participants, to
determine the extent to which geographical distances could explain variation in microbial community
taxonomic compositions between participant pairs. The correlation between community-level Bray-
Curtis (67) distances and participants’ spatial proximities (i.e., great-circle distances, kilometers) was
assessed using a Mantel test (68) with 1,000 matrix permutations. Analyses were conducted using the
subset of participants located in the continental United States who had not received antibiotics in the
last year. Different neighborhood sizes were investigated in order to detect the relevant spatial scale on
which significant distance-decay patterns in microbial community compositions emerged. To accomplish
this, we computed distance-decay relationships for a series of model adjacencies corresponding to
neighborhood radii of 100, 500, 1,000, 2,500, and 4,500 km among participants and adjusted P values
for multiple comparisons using the Benjamini-Hochberg procedure (69). We also studied spatial
correlations in phylogenetic community dissimilarities, calculated as weighted normalized UniFrac
distances, using the procedure described above. Analyses were conducted in the R statistical
programming environment.
The spatial autocorrelation of each individual taxon was assessed using Moran’s I statistic (70). Taxa
present in fewer than 10 samples were filtered, since these would not be sufficiently powered. Analyses
were conducted using binary spatial weight matrices, with neighborhoods of 0 to 50 km, 50 to 100 km,
and 100 to 250 km. The different neighborhoods were useful for detecting spatial autocorrelation at
different scales. All spatial weight matrices were row standardized. We checked for spatial autocorrela-
tion at three taxonomic ranks: class, genus, and OTU. We also considered whether there was autocor-
relation within subsets of individuals who were under 20 years old and between 20 and 70 years old;
those having IBD, no IBD, diabetes, and no diabetes; and those who had taken antibiotics within the past
week or year or not within the past year. The results presented above did not qualitatively depend on
the subset of individuals considered. Statistical significance was assessed using permutation tests, which
were implemented using a Markov chain Monte Carlo algorithm. To assess each P value, 100 chains were
run each starting from a different random permutation. Each chain had 1,000 iterations. We used
Bonferroni corrections to correct for multiple comparisons, with an overall significance level set to 0.05.
Analyses were run using custom Java code, optimized for running many spatial autocorrelation analyses
on large data sets (71).
Metadata cross-correlation. To account for covariance among metadata for effect size and variation
analyses, we examined the correlation between individual metadata variables, including technical
parameters. Groups in ordinal variables were combined if there was insufficient sample size (e.g., people
who reported sleeping less than 5 h were combined with those who reported sleeping 5 to 6 h into a
variable described as “less than 6”). The same transformations were used for effect size analysis. Any
group with fewer than 25 total observations was ignored during analysis; if this resulted in a metadata
column having no groups, the column was removed from analysis. The relationship between continuous
and ordinal covariates was calculated using Pearson’s correlation. Ordinal and categorical covariates were
compared using a modified Cramér V statistic (72). Continuous and categorical covariates were compared
with a Welch t test (72). We used 1  R as a distance between the covariates. Traversing the resulting
binary, weighted cluster tree starting at tip level into the direction of the root, i.e., bottom up, we
grouped tips together that are members of the same subtree after covering a distance of approximately
0.5 (branch length 0.29). A representative variable from each cluster was selected for analysis (Table S2).
Effect size calculations. Effect size was calculated on 179 covariates (including technical parame-
ters), selected from the cross correlation (Table S2). Ordinal groups with small sample sizes at the extreme
were collapsed as noted above. Individuals who reported self-diagnosis or diagnosis by an alternative
practitioner for medical conditions were excluded from the analysis. Any metadata variable with fewer
than 50 observations per group or that made up less than 3% of the total number of respondents was
also excluded from the effect size analysis. Continuous covariates were categorized into quartiles. For
each one of the 179 variables, we applied the mixed directional FDR (mdFDR) (73) methodology to test
for the significance of each pairwise comparison among the groups. For each significant pairwise
comparison, we computed the effect size using Cohen’s d (74) or the absolute difference between the
mean of each group divided by the pooled standard deviation. For analysis of diversity, we used Faith’s
phylogenetic diversity (alpha-diversity) and weighted and unweighted UniFrac distances (beta-diversity).
Variation analysis. Using the methodology reported in the supplemental material of reference 4, we
computed Adonis (75) using 1,000 permutations, over the sample sets used in the effect size calculations
as noted above, and applied Benjamini-Hochberg correction (FDR  0.1) to assess drivers of variation in
beta-diversity.
Meta-analysis movie. American Gut samples from all body sites were combined with data from an
infant time series (ITS) (49), a fecal transplant study (44), and recent work characterizing the microbiome
of patients in the intensive care unit (24). The combination of the data sets in the figshare supplementary
movie S2 in reference 50 required that all sequences were trimmed to an even length of 125 nucleotides.
All projects except for the infant time series were sequenced using an Illumina instrument. In order to
combine the data, we expressed the Illumina and non-Illumina data through a common reference
database. Specifically, the Deblur sOTUs from the Illumina data were mapped against the Greengenes
(19) database (13_8 release) using 99% similarity; the associations between the input sOTUs, and their
cluster memberships, were used to construct an OTU table based on the original sOTU-per-sample
sequence counts (i.e., summing the counts for all sOTUs in a common OTU). The infant time series data
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were picked using a closed reference OTU picking approach against the same reference at the same
similarity. The infant time series data set followed a closed reference OTU picking approach using 99%
similarity. The resulting two tables (from Illumina-generated data and the ITS data set) were merged and
analyzed using the Greengenes 99% tree. The table was rarefied to 1,250 sequences per sample.
Principal-coordinate projections were calculated based on unweighted UniFrac distance (13). The
principal-coordinate analysis was visualized and animated in EMPeror 1.0.0-beta8-dev (66, 76). The movie
was captured in QuickTime (Apple, Cupertino, CA) and edited with Premiere Pro (Adobe, San Jose, CA).
Integration with the Earth Microbiome Project. A precomputed 100-nt Deblur BIOM table repre-
senting the data in reference 1 was obtained from ftp://ftp.microbio.me/emp/release1/otu_tables/
deblur/. One-hundred-nucleotide (100-nt) Deblur tables were also obtained from Qiita for Hadza fecal
samples (Qiita study identifier [ID] 11358 [22]), ICU microbiome samples (Qiita study ID 2136 [24]), and
a longitudinal series which includes samples immediately prior to and following a large bowel resection
(Qiita study ID 10283, EBI accession no. ERP105968, unpublished); all samples were processed using the
EMP Illumina 16S V4 protocol. The EMP data set used a minimum sOTU count of 25; the same
threshold was applied to the other data sets included prior to merge. Blooms as identified by the
method in reference 15 were removed from all samples. This collection of BIOM tables was then
merged, yielding an OTU table representing 40,600 samples. sOTUs were restricted to those already
present in the EMP 100-nt fragment insertion tree, which represents 329,712 sOTUs. The table was
then rarefied to 1,000 sequences per sample, and unweighted UniFrac was computed using 768
processors with the aforementioned Striped algorithm. Visualizations and animations were per-
formed using EMPeror v1.0.0b12.dev0.
Extreme diet study state assessment. The sequence data from reference 25 were processed by
Deblur to assess 16S sOTUs in common with the AGP processing above. In order to assess a state
difference with PERMANOVA, we needed to control for sample independence within the longitudinal
sampling. To do so, we randomly selected one sample from each individual per diet, computed
PERMANOVA, and repeated the process 100 times. None of the trials produced a P value below 0.05.
VioScreen PCA and diet type Procrustes analysis. Before performing principal-component analysis
(PCA) on the informal diet questions, VioScreen variables that were categorical or received less than a
90% response among the 1,762 participants were excluded, leaving 1,596 participants. PCA was then
performed using the VioScreen information from these participants’ responses over 207 VioScreen
questions and then colored by their types of diet as answered in the AGP informal food survey. The
coordinates from the PCA were extracted. For the same samples, PCoA of unweighted UniFrac distances
was computed on the 16S data subset from the primary processing set. The coordinates from the PCA
and the PCoA were assayed for a measure of fitness using Procrustes as implemented in QIIME v1.9.1.
Beta-diversity added. To assess added beta-diversity, we applied the technique used in reference
5 (Fig. 3). Specifically, we randomly sampled n samples from the distance matrix 10 times, over an
increasing value of n. For each set of sampled distances, we computed the minimum observed distance.
sOTU novelty. To assess sOTU novelty, we randomly sampled n samples from an sOTU table 10
times, over an increasing value of n. At each sampling, we computed the number of sOTUs observed with
read counts within minimum thresholds. In other words, a minimum threshold of 1 is the number of
singletons observed in the sampled set, a minimum threshold of 2 is the number of singletons and
doubletons, etc.
Within-individual beta-diversity. Many of the individuals in the American Gut Project contributed
multiple samples but at uneven time intervals. In order to explore intrapersonal variation, we replicated
the analysis in the work of Lloyd-Price et al. (77) (Fig. 3). Specifically, we determined all time deltas
between a subject’s samples and gathered the distributions of beta-diversity between any two samples
binned by month. An individual is represented only a single time in a given month but may be
represented in multiple months if the individual had, for instance, contributed samples over the course
of a year.
HPLC-MS analysis. A total of 498 samples were selected for analysis via mass spectrometry.
Specifically, two groups were chosen. First, given the large body of primary literature describing the
negative impact of antibiotics on the gut microbiome, and the general interest in this topic from many
American Gut participants, we chose 279 samples from individuals (age, BMI, and country matched) who
self-reported not having taken antibiotics in the past year or reported having taken antibiotics in the past
month or week. We chose a second group of 219 samples collected from individuals who answered the
question “In an average week, how many different plants do you eat? (e.g., if you consume a can of soup
that contains carrots, potatoes, and onion, you can count this as 3 different plants; if you consume
multigrain bread, each different grain counts as a plant. Include all fruits in the total)” on the main
American Gut Project main survey and who had also completed the VioScreen food frequency ques-
tionnaire. When American Gut participants collect samples, they do so on a double-headed swab;
therefore, all samples chosen for this analysis had one remaining swab head (the first had been used for
DNA extraction and microbiome sequencing).
Cell culture sample preparation for metabolomics analysis. The supernatants collected from cell
cultures (see “Expanded bloom assessment” below) were processed to make them compatible with
HPLC-MS analysis. The solid-phase extraction (SPE) with wash was carried out to reduce the impact of cell
culture medium, which is highly detrimental for the electrospray ionization (ESI). The 30-mg sorbent
Oasis HLB (Waters, Waltham, MA) SPE cartridges were used to achieve broad metabolite coverage. The
cell samples were stored at 80°C and thawed at room temperature immediately prior to extraction. The
thawed samples were then centrifuged for 10 min at 1,200 rpm and extracted. For the SPE, the Oasis HLB
SPE cartridge was conditioned with 700 l of 100% HPLC-grade methanol and equilibrated with 700 l
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of HPLC-grade deionized (DI) water. The cell supernatant (~350 to 400 l) was loaded into the cartridge
and allowed to slowly elute. The loaded SPE wells were then washed with 800 l of 5% methanol in
water, and the absorbed material was slowly eluted with 200 l of 100% methanol. Vacuum up to
~20 lb/in2 was applied for the wells that did not elute within an hour. The collected eluent was stored
at 20°C until the HPLC-MS analysis.
Fecal sample preparation for metabolomics analysis. The swab tubes scheduled for analysis were
removed from the 80°C freezer and placed on dry ice for the duration of sample processing. Each tube
with a swab was logged by reading the barcode with a barcode scanner, and the swab was removed
from the tube and placed onto a Thermo Fisher Scientific (Waltham, MA) 2-ml deep-well 96-well plate
set on top of dry ice coolant. The top part of each swab’s stick was snapped off and discarded.
Immediately after all of the wells were filled with swabs, 200 l of HPLC-grade 90% (vol/vol) ethanol-
water solvent was added to each well using a multichannel pipette. Four blanks of unused swabs and
extraction solvent were included onto each plate. Each plate was then sealed with a 96-well plate lid,
sonicated for 10 min, and placed into the refrigerator at 2°C to extract samples overnight. After
extraction, the swabs were removed from wells and discarded, the plates were placed into a lyophilizer,
and the entire sample was dried down and then resuspended in 200 l 90% (vol/vol) ethanol-water. The
plates were resealed and centrifuged at 2,000 rpm for 10 min. The 100-l aliquots of sample were then
transferred onto a Falcon 96-well MS plate using a multichannel pipette, and each plate was immediately
sealed with sealing film. The MS plates were centrifuged at 2,000 rpm for 10 min and stored at 2°C until
analysis.
HPLC-MS analysis. The metabolomics analysis of samples was conducted using reverse-phase (RP)
high-performance liquid chromatography mass spectrometry (HPLC-MS). The HPLC-MS analysis was
performed on a Dionex UltiMate 3000 Thermo Fisher Scientific high-performance liquid chromatography
system (Thermo Fisher Scientific, Waltham, MA) coupled to a Bruker Impact HD quadrupole time of flight
(qTOF) mass spectrometer. The chromatographic separation was carried out on a Kinetex C18 1.7-m,
100-Å ultrahigh-performance liquid chromatography (UHPLC) column (50 mm by 2.1 mm) (Phenomenex,
Torrance, CA), held at 40°C during analysis. A total of 5 l of each sample was injected. Mobile phase A
was water, and mobile phase B was acetonitrile, both with added 0.1% (vol/vol) formic acid. The solvent
gradient table was set as follows: initial mobile phase composition was 5% B for 1 min, increased to 40%
B over 1 min and then to 100% B over 6 min, held at 100% B for 1 min, and decreased back to 5% B in
0.1 min, followed by a washout cycle and equilibration for a total analysis time of 13 min. The scanned
m/z range was 80 to 2,000, the capillary voltage was 4,500 V, the nebulizer gas pressure was 2  105 Pa,
the drying gas flow rate was 9 liters/min, and the temperature was 200°C. Each full MS scan was followed
by tandem MS (MS/MS) using collision-induced dissociation (CID) fragmentation of the seven most
abundant ions in the spectrum. For MS/MS, the collision cell collision energy was set at 3 eV and the
collision energy was stepped 50%, 75%, 150%, and 200% to obtain optimal fragmentation for differen-
tially sized ions. The scan rate was 3 Hz. An HP-921 lock mass compound was infused during the analysis
to carry out postprocessing mass correction.
MS data analysis. The collected HPLC-MS raw data files were first converted from Bruker’s d to
mzXML format and then processed with the open-source OpenMS 2.0 software (78) in order to
deconvolve and align each peak across different chromatograms (feature detection). The alignment
window was set at 0.5 min, the noise threshold was set at 1,000 counts, the chromatographic peak full
width at half-maximum (FWHM) value was set at 20, and the mass error was set at 30 ppm. All of the
peaks that were present in any of the blanks with a signal-to-noise ratio (S/N) below 10:1 were removed
from the final feature table. The number of features with corresponding MS/MS was as follows: VioScreen
study sample cohort, 5,144 total MS2 features; antibiotic study sample cohort, 8,288 total MS2 features.
The number of MS1 features is difficult to estimate exactly as it depends on feature detection settings
and the number of samples, but it is typically about 4- to 5-fold greater depending on the sample. For
all of the MS1 features detected across all samples, only ~1 to 5% are (35) present in an individual sample.
Molecular networking. Raw mass spectrometry data files were converted to the .mzXML format
using Bruker Data Analysis software and uploaded to the GNPS (https://gnps.ucsd.edu/) MassIVE mass
spectrometry database (https://massive.ucsd.edu/). Molecular networking (35) was performed to identify
spectra shared between different sample types and to identify known molecules in the data set. All
annotations are at level 2/3 according to the proposed minimum standards in metabolomics (36). The
data were filtered by removing all MS/MS peaks within 17 Da of the precursor m/z. MS/MS spectra were
window filtered by choosing only the top 6 peaks in the 50-Da window throughout the spectrum. The
MS spectra were then clustered with the MS-Cluster algorithm with a parent mass tolerance of 0.02 Da
and an MS/MS fragment ion tolerance of 0.02 Da to create consensus spectra (34, 75). Further, consensus
spectra that contained fewer than 4 spectra were discarded. A network was then created where edges
were filtered to have a cosine score above 0.65 and more than 5 matched peaks. The edges between two
nodes were kept in the network if and only if each of the nodes appeared in each other’s respective top
10 most similar nodes. The spectra in the network were then searched against GNPS spectral libraries
(34). The library spectra were filtered in the same manner as the input data. All library matches were
required to have a score above 0.7 and at least 6 matched peaks. Molecular networks were visualized and
mined using Cytoscape software (79).
Chemical annotations were carried out by automatic matching of fragmentation spectra to multiple
databases using Global Natural Product Social Molecular Networking (GNPS) (34) and then examining the
data at the MS/MS level by molecular networking (35). The goal is to retrieve spectra with identical and
similar fragmentation patterns and combine them into consensus nodes and clusters, respectively. The
consensus node spectra are then compared against public MS/MS libraries to provide molecular annotations
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(80). Further annotations could be suggested by examining the molecular network (35) (enabling the
propagation of annotations). The links to the job for the molecular networks used for this study can be found
at http://gnps.ucsd.edu/ProteoSAFe/status.jsp?task9bd16822c8d448f59a03e6cc8f017f43 (antibiotic sub-
set) and http://gnps.ucsd.edu/ProteoSAFe/status.jsp?taskd26ae082b1154f73ac050796fcaa6bda (type
of plant subset).
Molecular networking-based propagation of annotations. Library matching was done with the
GNPS reference library; however, many nodes that have no annotations are matched to a neighboring
node that did have a match. Consequently, manual annotation of compounds was carried out in two
steps. The exact mass of compounds and their MS/MS fragmentation spectra were matched to the
reference spectra found in supplementary information in reference 39 (Fig. S4A). In addition, commen-
damide and its analog were identified by matching the exact mass of the corresponding ion and by in
silico prediction of the MS/MS fragmentation spectra with CSI:FingerID (81) (Fig. S4B). For novel
molecules that were found within the cluster of compounds of interest but were not described in the
literature previously, the structure was postulated using annotation propagation from adjacent anno-
tated nodes in the cluster as described in reference 34 by assessing differences in parent mass and
fragmentation patterns. Annotations obtained with precursor and MS/MS matching are considered level
2 or 3 annotations according to the 2007 metabolomics standards initiative (36). All molecular network-
ing analyses and annotations are available here: antibiotic use subset (82), type of plant subset (83), cell
cultures of isolates (84), and fecal samples conetworked with the cell cultures (85). The raw data contain
a significant number of abundant features originating from swab polymers. Therefore, selective back-
ground peak removal was carried out specifically for the polymer compounds originating from swabs
that were used for the sample collection. The m/z shifts that correspond to the polymer repeating units
(44.0262, 88.0524, 132.0786, and 176.1049) were identified with the GNPS m/z difference frequency plot.
The network clusters that contained nodes with the corresponding mass differences were deemed to
belong to polymers, and all member nodes of the network clusters were removed from the feature table
(a total of 1,632 features/nodes). Principal-coordinate analysis (PCoA) using a Hellinger distance (86)
matrix was used to confirm that the batch effect corresponding to the batches of swabs was mitigated
prior to further analysis. To confirm putative annotations, authentic standards were purchased for linoleic
acid (LA; Spectrum Laboratory Products, Inc., USA), conjugated linoleic acid (CLA; mixture of 4 isomers:
9,11 and 10,12 isomers, E and Z) (Sigma-Aldrich, USA), and selected antibiotics—tetracycline, oxytetra-
cycline, and doxycycline (Abcam Inc., USA). For level 1 identifications, each authentic compound was
analyzed under identical experimental conditions and retention times (RTs) and MS/MS spectra were
compared with putatively annotated compounds.
Molecular networking-based propagation of annotations for the N-acyl ligands. The annotation
of GPCR agonist compounds was not possible via direct library matching, as their spectra are not present
in any MS libraries, but direct comparison with fragmentation patterns presented in reference 36 allowed
us to establish these compounds’ identity with level 3 identification. Consequently, manual annotation
of compounds was carried out in two steps. The exact mass of compounds and their MS/MS fragmen-
tation spectra were matched to the reference spectra found in the supplemental material (Fig. S4A).
Compound m/z 611.5357 was identified in this fashion. In addition, commendamide (330.2640) and its
analog (m/z 344.2799) were identified by matching the exact mass of the corresponding ion and by in
silico prediction of the MS/MS fragmentation spectra with CSI:FingerID (81) (Fig. S4B). For novel
molecules that were found within clusters of compounds of interest but were not described in the
literature previously, the structure was postulated using annotation propagation from adjacent anno-
tated nodes in the cluster as described in reference 34 by assessing differences in parent mass and
fragmentation patterns. The key structure, m/z 387.322, has been annotated as N-3-OH-palmitoyl
ornithine based on the exact mass and previous annotation (39) as well as analysis of fragmentation
patterns to confirm structural moieties of fragments (Fig. S4C). The rest of the structural assignments
have been propagated from that structure. The ornithine moiety has been determined to be present in
each structure (due to the presence of the signature ion with m/z 115.09), and acylation of the hydroxyl
is not possible due to insufficient mass of the structures; thus, the changing mass was postulated to
correspond to different lengths of the alkyl substituent (Fig. 6).
Selective feature detection. Selective feature extraction was performed with open-source MZmineb2
software (87). To separate closely eluting LA and CLA isomers as well as separate various N-acyl amides,
crop filtering with a retention time (RT) range of 5.4 to 6.0 min and an m/z range of 281.246 to 281.248
was applied to all chromatograms. Mass detection was performed with a signal threshold of 1.0E2 and
an 0.6-s minimum peak width. The mass tolerance was set to 20 ppm, and the maximum allowed
retention time deviation was set to 5 s. For chromatographic deconvolution, the baseline cutoff
algorithm with a 5.0E1 signal threshold was used. The maximum peak width was set to 0.5 min. Similarly,
the MS feature for the reference compound stercobilin was extracted with a crop filter RT range of 2.0
to 4.0 min and an m/z range of 595.345 to 595.355. The stercobilin reference compound was used to
assess the variability of chromatographic retention times to ensure that the retention times of com-
pounds of interest (LA and CLA in particular) were correctly identified. After isotope peak removal, the
peak lists of all samples were aligned within the corresponding retention time and mass tolerances. Gap
filling was performed on the aligned peak list using the peak finder module with 1% intensity, 10-ppm
m/z tolerance, and 0.05-min RT tolerance, respectively. After the creation and export of a feature matrix
containing the feature retention times, exact mass, and peak areas of the corresponding extracted ion
chromatograms, we added sample metadata to the feature matrix metadata of the samples.
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The selective feature extraction with the same settings has been performed for all of the detected
compounds listed in Fig. S4A to I (the m/z range crop filter window was set for corresponding m/z for
each compound).
Correlations of metabolites with metadata. We have investigated correlations between metabo-
lites (especially those of interest, such as N-acyl amides) and all of the categories in the metadata. The
data were subsetted into the VioScreen and antibiotic cohorts and normalized using probabilistic
quotient normalization (88). In order to test the association of the metabolites with the categorical
metadata fields, we performed the Kruskal-Wallis test followed by Benjamini and Hochberg FDR
correction for all metabolites. The significant metabolite-metadata associations (adjusted P value  0.05)
were further connected to GNPS spectral library matches associating the MS1 feature with the MS2
precursor ion in a 10-ppm mass window and 20-s retention time window. The results are summarized in
Table S5.
Data pretreatment for statistical analysis. A PCoA plot using Hellinger distance (distance matrix,
Hellinger; grouping, hierarchical cluster analysis) was built with all samples in the subset; one sample was
found to be an outlier and removed. The data were then filtered to remove features with near-constant,
very small values and values with low repeatability using the interquartile range (IQR) estimate. A
detailed description of the methodology is given in reference 89. The samples were normalized by sum
total of peak intensities, an important step due to the large variability of the fecal material load on
different swabs. To reduce the effect of background signal and make the sum normalization appropriate,
the subtraction of blank and polymer peak features was conducted prior to analysis, as described above.
The data were further scaled by mean centering and dividing by standard deviation for each feature.
The data were split into two groups for downstream analysis. Group 1 contained samples from
individuals answering “more than 30” (n  41) and “less than 10” (n  44) to the main American Gut
Project survey question “In an average week, how many different plants do you eat?” Group 2 contained
samples from individuals answering “antibiotic use within last week” (n  56) and “I have not taken
antibiotics in the past year” (n  115) to the main American Gut Project survey question “I have taken
antibiotics in the last ____.” for the antibiotic history study, correspondingly.
The resultant feature tables were used as input for the MetaboAnalyst software (90). Partial least-
squares discriminant analysis (PLS-DA) (65) was used to explore and visualize variance within data and
differences among experimental categories. Random forests (91) (RF) supervised analysis was used to
further verify the validity of determined discriminating features.
Expanded bloom assessment. The American Gut Project data set now spans multiple omics types
and includes data that were unavailable during the analysis described in the work of Amir et al. (15). To
better understand how the blooming organisms impacted the samples in the American Gut, we (i)
performed an additional set of 16S-based experiments; (ii) cultured historical samples covering a range
of bloom fractions, characterized their metabolites, and sequenced the isolates; (iii) performed shotgun
metagenomics sequencing on the “high-bloom” samples; (iv) ran the set of samples previously run for
HPLC-MS (e.g., the plant and antibiotic cohorts) for shotgun metagenomics; and (v) ran the storage
samples from reference 17 for shotgun metagenomics. The additional sequencing effort was to provide
a basis to assess whether functional potential driven by the blooms was impacting any of the biological
results discussed in this paper. The additional HPLC-MS work was to characterize the metabolites specific
to the blooms to remove them from analysis.
16S-based bloom experiments. Effect size calculations were computed prior to and following the
removal of bloom reads using the procedure described by Amir et al. (15). The fraction of reads recruiting
to blooms was included as a covariate. Effect sizes were assessed over Faith’s phylogenetic diversity (9),
unweighted UniFrac (13), and weighted UniFrac (92). We then computed Pearson and Spearman
correlations of the effect sizes, per metric, between the bloom and bloom-removed result (Fig. 2C and
D). In addition to the effect size calculations, we also tested whether the bloom fraction was correlated
with any metadata category and did not observe significant correlations.
We then tested the removal of blooms from other studies in which room-temperature shipping was
not performed by retrieving a wide variety of human fecal studies from Qiita. UniFrac distance matrices
were computed prior to and following bloom removal, followed by Mantel tests. The results of this
procedure are outlined in Table S4.
Finally, we correlated the relative intensities of the HPLC-MS data associated with the antibiotic and
plant cohorts against the fraction of blooming reads. Critically, we observed a set of spectra that are
significantly correlated (Table S5) with this fraction. On annotation using molecular networking (dis-
cussed in detail under “HPLC-MS analysis” above), we observed these metabolites to putatively be
lysophosphatidylethanolamine (LysoPE), a lysophospholipid (LPL) which has previously been associated
with the release of colicin (93). These metabolites were removed from subsequent analyses.
Culturing. Primary specimens (n  214) were selected from three plates based on the median
fraction of reads recruiting to the blooms across the plate, whether the primary specimen still existed,
and the aim of gathering samples from at least the United States (n  116) and United Kingdom (n 
73); additional countries were included in smaller sample sizes and include Australia (n  7), Germany
(n  7), Canada (n  3), Croatia (n  2), Belgium (n  2), France (n  1), Austria (n  1), Sweden (n 
1), and the Czech Republic (n  1). The bloom typically observed in these samples (and in the full AGP
data set) is E. coli (ID 04195686f2b70585790ec75320de0d6f from reference 15), although a few of the
other bloom sequences were represented at high read fraction as well. Samples were retrieved from
80°C and thawed on ice. The swab head was broken off into 500 l sterile 1 Dulbecco’s phosphate-
buffered saline and vortexed vigorously for 30 s. Serial dilutions from this initial stock were made,
including 1:10,000 and 1:1,000,000. Ten microliters of the 1:10,000 dilution was inoculated into 1.5 ml
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sterile tryptic soy broth (TSB; BD catalog no. 2253534) in sterile 96-deep-well plates (community cultures
[CC]) and incubated overnight at 37°C on an orbital shaker at 500 rpm. Values of optical density at 600
nm (OD600) above 0.1 (TSB controls measured ~0.08) were counted as positive growth. Samples with a
high bloom fraction tended to grow overnight under ambient conditions, and samples with a low bloom
fraction tended to not grow under these conditions (Fig. 2A). Additionally, 100 l of each dilution was
plated onto tryptic soy agar using sterile glass beads and incubated overnight at 37°C. The following
morning, a picture of the best dilution was captured and the most representative colony was selected
from each plate and inoculated into 1.5 ml sterile TSB for overnight incubation as described above
(isolates [IS]). The following morning, OD600 measurements were taken and the cultures were pelleted at
3,000  g for 5 min. The supernatant and cell pellets were stored at 20°C for metabolomic analysis and
DNA extraction, respectively.
Shotgun sequencing of cultured specimens. Shotgun sequencing was performed on all isolates
and community cultures using a 1:10 miniaturized Nextera library preparation with 1 ng genomic DNA
(gDNA) input or up to 1 l and a 15-cycle PCR amplification. Libraries were quantified with the PicoGreen
double-stranded DNA (dsDNA) assay kit, and 50 ng of each library (or a 4-l maximum) was pooled. The
library was size selected for 200 to 700 bp using the Sage Bioscience Pippin Prep and sequenced as a
paired-end 150-cycle run on an Illumina HiSeq 2500 v2 sequencer in Rapid Run mode at the UCSD IGM
Genomics Center. Sequence processing, including assembly performed as described for metagenomic
processing below, with the exception that “--meta” was not used with SPAdes (94), and read binning
against the resulting contigs was not performed. For each isolate, contigs with abnormally high or low
coverage as defined by the 1.5 interquartile range (IQR) rule were dropped. The characterization of the
metabolites from the supernatant using HPLC-MS is discussed under “HPLC-MS analysis” above.
Following assembly of the draft genomes, taxonomic assessment by Kraken (95) revealed that of the
119 successfully sequenced colony isolate cultures, 95 matched the bloom organisms identified by Amir
et al. (15). Compellingly, 70 of these isolate genomes contained exact 16S sequence matches to a bloom
organism identified by reference 15, including 65 which matched the dominant E. coli bloom in the
American Gut (Table S4).
Biosynthetic gene cluster analysis of isolates. The read data for the isolates were then assessed for
predicted biosynthetic gene clusters (BGCs). We used biosyntheticSPAdes (D. Meleshko, H. Mohimani, I.
Hajirasouliha, M. H. Medema, A. Korobeynikov, and P. Pevzner, submitted for publication) to analyze BGCs
in the assembly graph of individual genomes. Below, we focus on the longest BGCs that are particularly
difficult to reconstruct based on ad hoc analysis of contigs and reveal their variations (which likely
translate into variations of their natural products). Some of the reconstructed long BGCs are ubiquitous
(shared by many isolates, albeit with some variations), while others are unique, e.g., present in a single
or a small number of isolates. We identified BGCs, representing in the alphabet of their domains
(Table S4), and uncovered variations in their sequence across multiple isolates. Specifically, we found a
ubiquitous BGC similar to the elusive peptide-polyketide genotoxin colibactin and a unique surfactin-like
BGC. Colibactin triggers DNA double-strand breaks in eukaryotic cells (96, 97) and induces cellular
senescence and metabolic reprogramming in affected mammalian cells (98). Of the 11 samples contain-
ing the longest colibactin-like BGC, 10 of them contained the exact E. coli bloom 16S sequence described
above; the 11th isolate was actually a canine fecal sample plated alongside human samples (as the AGP
allows participants to submit pet samples).
Although colibactin is frequently harbored by various E. coli strains, the variations of colibactin BGCs
across various isolates have not been studied before. Genomic analysis revealed wide variations in
colibactin-like BGCs, suggesting that various strains produce related but not identical variants of natural
products (99). These variations may give rise to the suite of LysoPE-associated spectra identified between
the 16S and HPLC-MS data sets.
Shotgun sequencing of the high-bloom and storage samples. Previously extracted DNA from the
high-bloom samples used for culturing was obtained, as was previously extracted DNA from the work of
Song et al. (17). Shotgun sequencing libraries from a total of 5 ng (or 3.5 l maximum) gDNA were used
in a 1:10 miniaturized Kapa HyperPlus protocol with a 15-cycle PCR amplification. Libraries were
quantified with the PicoGreen dsDNA assay kit, and 50 ng (or 1 l maximum) of each library was pooled.
The pool was size selected for 300 to 700 bp and sequenced as a paired-end 150-cycle run on an Illumina
HiSeq 2500 v2 sequencer in Rapid Run mode at the UCSD IGM Genomics Center. Sequence processing,
including assembly, was performed as described for metagenomic processing below.
Functional assessment of conjugated and nonconjugated linoleic acid. To investigate the
metabolic potential of the gut microbiome for producing conjugated linoleic acid from linoleic acid, we
estimated the abundance of linoleic acid isomerase (LAI) in the fecal metagenome. We focused this
investigation on the “plant” cohort, which were samples selected to maximize the difference between
the number of types of plant metadata category as discussed above. First, we translated the assembled
metagenomes to metaproteomes using Prodigal gene prediction software. To map LAI to these meta-
proteomes, we used a representative LAI protein sequence (UniProt D2BQ64), which was matched
against UniProtKB (via https://www.ebi.ac.uk/Tools/hmmer/) for multiple sequence alignment (MSA). The
resulting MSA file in Clustal format was then used to generate a hidden Markov model (HMM) profile for
LAI using hmmbuild in HMMER software (100). Subsequently, we mapped the resulting HMM profile to
sample metaproteomes using hmmsearch with an E value threshold of 10E5. We calculated abun-
dances of LAI per sample based on abundance (coverage  length) of LAI containing contigs in each
sample, normalized to total sample biomass, and performed linear regression between LAI abundances
and bloom fraction. We did not note any correlation between metabolic potential of gut metagenome
to produce LAI and the fraction of blooming bacteria (samples with no LAI hits were removed from this
American Gut: an Open Platform for Microbiome Research
May/June 2018 Volume 3 Issue 3 e00031-18 msystems.asm.org 21
 on O
ctober 29, 2020 at U
niversitatsbibliothek
http://m
system
s.asm
.org/
D
ow
nloaded from
 
analysis). Similarly, there was no correlation between CLA abundances and bloom fraction in the samples.
These results suggest that our report on the differential abundance of CLA in subjects with different
dietary practices (with respect to the number of different types of plants consumed) is unlikely to be
confounded by the presence of blooming bacteria.
Storage sample assessment. Metagenomic reads from the storage samples were mapped to the
169 isolate assemblies. We then ran model comparison tests on each to determine which mappings were
significantly different between frozen samples and samples left out at ambient temperatures for various
periods of time. Using the ‘lme’ package (101) in R (v3.3.3, R Core Team, 2017), linear mixed-effects
models were applied to the abundances, with individual treated as the random effect. Mappings were
considered to be significantly associated with temperature if the model was significantly improved
(ANOVA P 	 0.05) by incorporating a fixed effect of temperature. Seven mappings to isolates were found
to be significantly increased in samples stored at ambient temperatures compared to frozen samples in
both storage studies, of which 3 contained the 16S of the dominant E. coli bloom in the AGP samples and
2 contained the 16S from other blooms recognized by the work in reference 15.
Shotgun sequence processing. Raw Fastq files were processed using Atropos v1.1.5 (102) to remove
adapters and low-quality regions. Putative human genome contaminations were identified and removed
by using Bowtie 2 v2.3.0 (103) with the “--very-sensitive” option against the human reference genome
GRCh37/hg19.
Sequences were assigned taxonomy using Kraken v1.0.0 (95) against the “standard” database built
according to the Kraken manual, which contains all complete bacterial, archeal, and viral genomes
available from NCBI RefSeq as of 3 August 2017. Results were processed using Bracken v1.0.0 (104) to
estimate the relative abundance of species-level taxa.
Metagenome sequencing data were assembled using SPAdes v3.11.1 (94) with the “--meta” flag
enabled (105). Contigs of 
1 kb in length were retained and fed to the prokaryotic genome annotation
pipeline Prokka v1.12 (106). Putatively individual genomes were inferred using MaxBin2 v2.2.4 (107).
In parallel, contigs were sheared into 200-bp fragments and taxonomy was assigned using Kraken
(see above). For each contig, the most assigned taxon at each taxonomic rank and the proportion of
sequences assigned to it were inferred.
A total of 3,725 genome bins were identified from 677 out of 780 AGP metagenomes, with 5.50 
4.05 bins per sample and a maximum bin number of 30. Bins with completeness of 50% were dropped,
leaving 1,029 bins from 464 samples (2.22  1.97 bins per sample, maximum bins  19).
Antimicrobial resistance gene assessment. There are 780 metagenome shotgun samples in total,
of which 713 have at least 100,000 reads and have corresponding metadata. Of these, 240 belong to the
antibiotic (“Abx”) cohort, and 203 belong to the “plant” cohort.
We ran FragGeneScan (v1.30 “run_FragGeneScan.pl -complete0 -trainillumina_10 -genome
input.fa -outout.file”) (108) on quality-controlled reads to infer partial protein sequences and
then ran HMMER (v3.1b2 “hmmsearch --cut_tc --cpu 4 --tblout out.file resfam.db input.file”)
(109) against the ResFam database, version 1.2.2 (110, 111), to identify putative antibiotic resistance
genes.
The ResFam database contains entries for 170 antimicrobial resistance (AMR) gene families. Of these,
122 belong to at least 1 of 16 antibiotic classes, all 170 belong to at least 1 of 21 mechanism classes, and
42 belong to 5 beta-lactamase classes in the Ambler classification.
We normalized the counts against the total number of reads per sample. The results were converted
to BIOM tables, filtered to retain valid samples only (see above), and collapsed from family to the three
types of classes (see above). The relative abundance table containing antibiotic classes was used for
downstream analysis.
For each metadata category, the upper and lower extrema were selected for comparison. The
Kruskal-Wallis H test (using the SciPy command Kruskal) was performed to assess the differential
abundance between upper and lower extrema for each of the nine antibiotic classes. The H statistic and
P value were reported for each antibiotic class.
Specifically, for the cohort “Abx,” the metadata column “antibiotic_history” was tested. Categories
“Week” and “Month” were merged into “within 1 month”; “I have not taken antibiotics in the past year.”
was abbreviated as “beyond 1 year.” Other categories were omitted.
For the cohort “plant,” metadata column “types_of_plants” was tested. Categories “less than 5” and
“6 to 10” were merged into “10 or less”; “More than 30” was retained; others were omitted.
Filtering bacterial blooms for metabolomics analysis. To assess and account for the impact of the
metabolites contributed by these organisms, we have performed HPLC-MS analysis of cultures of
blooming organisms to establish possible contributions, as described above. It was found that there is
a negligible overlap of the bloom-associated metabolites with the compounds detected in AGP samples
(Fig. 2B). Furthermore, we have verified that none of the compounds discussed in this work (LA, CLA, and
compounds in Fig. S4A to I) are present in these bloom cultures. The main organism implicated in bloom
was determined to be E. coli, as described earlier, and MS data corroborate these findings (network not
shown).
Considering that the metabolites resulting from microbial activity in cultures can differ significantly
from those in vivo (e.g., many of the metabolites could originate not from de novo synthesis but rather
from microbial modifications of external compounds that are not present in medium, e.g., from the host),
we also explored associations of metabolites in AGP metabolomics samples and blooms. Spearman rank
correlation analysis of the fraction of 16S reads in a sample reporting as bloom to metabolites observed
in the same samples revealed several features that correlate significantly (Table S5). There exists a
significant overlap between the antibiotic and VioScreen study subsets, indicating a potential common
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origin of these features. The strongest correlation was found for the feature m/z 480.3106 with multiple
bloom organisms (^2  0.25 for E. coli at P  1e40). This feature was found to also significantly
correlate with the principal coordinates of the PCoA, with and without blooms in the UniFrac matrices
for both subsets. The tentative annotation of this feature is LysoPE, a lysophospholipid (LPL). The
production of LPLs in vivo is a result of phospholipase A enzymatic activity associated with Gram-
negative bacteria. It is known that LysoPE is essential for release of colicin (93). Colicin (by itself not
detectable with the MS methodology in this study due to very high molecular mass) is a bacteriocin
related to microbial warfare and is known to be produced by E. coli, the major bloomer in AGP. It can
be suggested that the blooming of an organism is related to attempting to kill competitors to maximize
nutrient availability. Importantly, removal of all of the features associated with bloom does not alter the
metabolomics results at all, which indicates that all of the observed biological trends reported here are
not related to blooms.
Mental health in the American Gut Project. From the AGP cohort, we selected subjects who
endorsed a mental health disorder (depression, schizophrenia, PTSD, and/or bipolar disorder). This
resulted in 1,140 subjects. Six hundred thirty-six subjects endorsed at least one of the exclusion criteria
(antibiotic use in the last year, IBD, Clostridium difficile infection, pregnancy, Alzheimer’s disease, anorexia
or bulimia, history of substance use disorder, epilepsy or seizure disorder, kidney disease, and phenyl-
ketonuria). Out of the remaining 504 subjects, 319 did not provide information regarding country of
residence, hence forming a case cohort of 185 subjects. The remaining samples were further filtered
down to 125 samples to include only high-quality fecal microbiome data (at least 1,250 sequences/
sample) at a single time point per subject. For those cases, we created a 1:1 matched sample of patients
and nonpsychiatric comparison (NC) participants based on age (5 years), BMI, history of diabetes,
smoking frequency, country of residence, census region (if in the United States), and sequencing plate.
For each of the cohorts, we calculated beta-diversity distance matrices using Bray-Curtis dissimilarity and
weighted UniFrac. On the resulting matrices, we ran pairwise PERMANOVA with 999 permutations
between “cases” (people who reported mental illness) and NCs (outmatched control data set). Differential
abundance testing was performed using the permuted mean difference test at 10,000 permutations, with
discrete FDR (112) correction at alpha  0.1.
Data availability. All sequence data and deidentified participant responses can be found in EBI
under project PRJEB11419 and Qiita study ID 10317. Per-sample EBI accession numbers and download
links partitioned by the sequencing run are described in Table S1. The sOTU table following bloom removal
containing the 9,511 samples used in the manuscript can be accessed from figshare in both read count (113)
and relative abundance (114), as well as the corresponding phylogeny (115), sample metadata (116), collated
alpha-diversities (117), and unweighted (118) and weighted (119) UniFrac distance matrices. For the mass
spectrometry, data are accessed through https://gnps.ucsd.edu: MSV000080187 (antibiotic study cohort),
MSV000080186 (plant consumption frequency study cohort), and MSV000081777 (cell cultures of
blooms). For the novel annotated structures of N-acyl amides, the reference MS/MS spectra at GNPS
are CCMSLIB00004679232, CCMSLIB00004679233, CCMSLIB00004679234, CCMSLIB00004679235,
CCMSLIB00004679236, CCMSLIB00004679237, CCMSLIB00004679238, CCMSLIB00004679239, and
CCMSLIB00004679240. All of the raw data are publicly available at the UCSD Center for Computational
Mass Spectrometry (36) (data set ID MassIVE MSV000080179). The additional sequence data generated
from the American Gut samples were deposited in EBI under the American Gut accession (ERP012803),
and the storage sample data were deposited under their accession (ERP015155). The deidentified
participant and sequence data for the American Gut are available from the European Bioinformatics
Institute under accession number ERP012803. Per-sample accession numbers are included in the
supplemental material (Table S1). The EBI accession includes more samples than presented here, as
consent for some samples was obtained after the analysis was completed.
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